Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

BMC medical genetics - 30 Jan 2009

Azzato Elizabeth M, Morton Lindsay M, Bergen Andrew W, Wang Sophia S, Chatterjee Nilanjan, Kvale Paul, Yeager Meredith, Hayes Richard B, Chanock Stephen J, Caporaso Neil E

Abstract excerpt

BACKGROUND: To investigate the contribution of the dopamine transporter to dopaminergic reward-related behaviors and anthropometry, we evaluated associations between polymorphisms at the dopamine transporter gene(SLC6A3) and body mass index (BMI), among participants in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. METHODS: Four polymorphisms (rs6350, rs6413429, rs6347 and the 3'...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Body Mass Index
Share to Cross-Sectional Studies
Share to Dopamine Plasma Membrane Transport Proteins
Share to Gene Frequency
Share to Likelihood Functions
Share to Minisatellite Repeats
Share to Overweight

Source

Open in PubMed Open full text

Identifiers

PMID: 19183461
DOI: 10.1186/1471-2350-10-9
PMCID: PMC2640369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.PMID 19183461Read ↗

Obesity is associated with genetic variants that alter dopamine availability.Semantic proximity Read ↗

Two dopaminergic genes, DRD4 and SLC6A3, are associated with body mass index in a Colombian sample of young adults.Semantic proximity Read ↗

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.Semantic proximity Read ↗

Dopamine transporter genotype as a risk factor for obesity in African-American smokers.Semantic proximity Read ↗

Positive association of obesity with single nucleotide polymorphisms of syndecan 3 in the Korean population.Semantic proximity Read ↗

Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight.Semantic proximity Read ↗

Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism.Semantic proximity Read ↗

Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis.Semantic proximity Read ↗

Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.Semantic proximity Read ↗

Association between the ROBO1 gene and body mass index in patients using antipsychotics.Semantic proximity Read ↗

Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene.Semantic proximity Read ↗

Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.